MUC16 and colorectal cancer: For example, Li et al. [13] used the same approach that we used in this paper to identify subgroups of patients with distinct longitudinal CEA, CA19-9, and CA125 trajectories from a retrospective, longitudinal cohort of patients with colorectal cancer who underwent curative resection and investigated the overall survival and the recurrence-free survival of the patients in these groups.